Terms: = Pancreatic cancer AND NFKB2, ENSG00000077150, LYT10, LYT-10, 4791
8 results:
1. The radiomics nomogram predicts the prognosis of pancreatic cancer patients with hepatic metastasis after chemoimmunotherapy.
Lu W; Wu G; Miao X; Ma J; Wang Y; Xu H; Shentu D; Xue S; Xia Q; Wang Y; Wang L
Cancer Immunol Immunother; 2024 Mar; 73(5):87. PubMed ID: 38554161
[TBL] [Abstract] [Full Text] [Related]
2. Reconstructing topography and extent of injury to the superior mesenteric artery plexus in right colectomy with extended D3 mesenterectomy: a composite multimodal 3-dimensional analysis.
Luzon JA; Thorsen Y; Nogueira LP; Andersen SN; Edwin B; Haugen HJ; Ignjatovic D; Stimec BV
Surg Endosc; 2022 Oct; 36(10):7607-7618. PubMed ID: 35380284
[TBL] [Abstract] [Full Text] [Related]
3. Receptor-Interacting Serine/Threonine-Protein Kinase-2 as a Potential Prognostic Factor in Colorectal cancer.
Jaafar RF; Ibrahim Z; Ataya K; Hassanieh J; Ard N; Faraj W
Medicina (Kaunas); 2021 Jul; 57(7):. PubMed ID: 34356990
[No Abstract] [Full Text] [Related]
4. Evolutionary routes and KRAS dosage define pancreatic cancer phenotypes.
Mueller S; Engleitner T; Maresch R; Zukowska M; Lange S; Kaltenbacher T; Konukiewitz B; Öllinger R; Zwiebel M; Strong A; Yen HY; Banerjee R; Louzada S; Fu B; Seidler B; Götzfried J; Schuck K; Hassan Z; Arbeiter A; Schönhuber N; Klein S; Veltkamp C; Friedrich M; Rad L; Barenboim M; Ziegenhain C; Hess J; Dovey OM; Eser S; Parekh S; Constantino-Casas F; de la Rosa J; Sierra MI; Fraga M; Mayerle J; Klöppel G; Cadiñanos J; Liu P; Vassiliou G; Weichert W; Steiger K; Enard W; Schmid RM; Yang F; Unger K; Schneider G; Varela I; Bradley A; Saur D; Rad R
Nature; 2018 Feb; 554(7690):62-68. PubMed ID: 29364867
[TBL] [Abstract] [Full Text] [Related]
5. Silencing pancreatic adenocarcinoma upregulated factor (PAUF) increases the sensitivity of pancreatic cancer cells to gemcitabine.
Gao CC; Xu XL; Li F; Gong BG; Liu S; Cui YQ; Sun HC; Xu PY; Zheng YM; Jiang H
Tumour Biol; 2016 Jun; 37(6):7555-64. PubMed ID: 26684804
[TBL] [Abstract] [Full Text] [Related]
6. Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study.
Kempers MJ; Kuiper RP; Ockeloen CW; Chappuis PO; Hutter P; Rahner N; Schackert HK; Steinke V; Holinski-Feder E; Morak M; Kloor M; Büttner R; Verwiel ET; van Krieken JH; Nagtegaal ID; Goossens M; van der Post RS; Niessen RC; Sijmons RH; Kluijt I; Hogervorst FB; Leter EM; Gille JJ; Aalfs CM; Redeker EJ; Hes FJ; Tops CM; van Nesselrooij BP; van Gijn ME; Gómez García EB; Eccles DM; Bunyan DJ; Syngal S; Stoffel EM; Culver JO; Palomares MR; Graham T; Velsher L; Papp J; Oláh E; Chan TL; Leung SY; van Kessel AG; Kiemeney LA; Hoogerbrugge N; Ligtenberg MJ
Lancet Oncol; 2011 Jan; 12(1):49-55. PubMed ID: 21145788
[TBL] [Abstract] [Full Text] [Related]
7. Identification of serum biomarkers for pancreatic adenocarcinoma by proteomic analysis.
Guo J; Wang W; Liao P; Lou W; Ji Y; Zhang C; Wu J; Zhang S
Cancer Sci; 2009 Dec; 100(12):2292-301. PubMed ID: 19775290
[TBL] [Abstract] [Full Text] [Related]
8. Overexpression of the opioid growth factor receptor potentiates growth inhibition in human pancreatic cancer cells.
Zagon IS; Verderame MF; Hankins J; McLaughlin PJ
Int J Oncol; 2007 Apr; 30(4):775-83. PubMed ID: 17332915
[TBL] [Abstract] [Full Text] [Related]
